- Home
- A-Z Publications
- Current Medicinal Chemistry
- Previous Issues
- Volume 10, Issue 4, 2003
Current Medicinal Chemistry - Volume 10, Issue 4, 2003
Volume 10, Issue 4, 2003
-
-
Recent Advances in Peroxisome Proliferator-Activated Receptor Science
Authors: B.G. Shearer and W.J. HoekstraThe peroxisome proliferator-activated receptor (PPAR) family of nuclear receptors, a set of three receptor sub-types encoded by distinct genes, function as lipid sensors to regulate a broad range of genes in many metabolically active tissues. Synthetic PPAR agonists have exhibited therapeutic benefits in treating diabetes and cardiovascular diseases. The discovery of PPAR-specific ligands has led to significant advan Read More
-
-
-
Abuse of Clenbuterol and its Detection
Authors: A. Prezelj, A. Obreza and S. PecarClenbuterol and other β-agonists are commonly misused as repartitioning agents in meat production and as doping substances to improve athletic performance. Numerous reports on food poisoning throughout Europe prompted the EU regulatory offices and FDA to implement a ban on the use of β-agonists as growth promoters. Several analytical methods have been developed for detecting illegal administration of these compo Read More
-
-
-
Drugs that Activate Specific Nitric Oxide Sensitive Guanylyl Cyclase Isoforms Independent of Nitric Oxide Release
By S. BehrendsNitric oxide (NO) releasing drugs have helped patients suffering from angina pectoris for more than a century. In the 1970s NO-sensitive guanylyl cyclase was identified as the target of NO. Since then, three different isoforms of the enzyme have been identified. All NO-releasing drugs act by binding of NO to the prosthetic heme group common to all three isoforms. They thus act all as isoform-unspecific substances. This revie Read More
-
-
-
Reservoirs of HIV Replication After Successful Combined Antiretroviral Treatment
Authors: L. Belmonte, P. Bar, M.M.E. de Bracco and B.H. Ruibal-AresSustained reduction of viral replication can be achieved in HIV infected patients after treatment with combinations of drugs (HAART) that inhibit the viral reverse transcriptase, and protease enzymes. However, replication competent virus can still be recovered from latently infected resting memory CD4+ T-cell lymphocytes. Moreover, ”covert“ virus replication has been demonstrated in patients who experienced reductions i Read More
-
-
-
Conformational Analysis and Molecular Properties of N-(Substituted Phenylcarbonylamino)- 4-(1-Hydroxymethylphenyl)-1,2,3,6-Tetrahydropyridines
Authors: C.O. Okoro, T.L. Wilson and K.K. ReddaThe three-dimensional structures of active derivatives of N-(substitutedphenylcarbonylamino)-4-(1- hydroxymethylphenyl)-1,2,3,6-tetrahydropyri-dines, which have previously been shown to possess antiinflammatory activities, were built using BIOMEDCAche 5.0 software program. In addition, the three dimensional structures of some of the inactive ones were similarly generated. The conformational analysis, molecular and ele Read More
-
-
-
Poly(ADP-Ribose) Polymerase Inhibitors
Authors: G.J. Southan and C. SzabPoly(ADP-ribose) polymerase-1 (PARP-1) is the principal member of the PARP enzyme family consisting of PARP-1 and several recently identified novel poly(ADP-ribosyl)ating enzymes. PARP-1 functions as a DNA damage sensor and signalling molecule. Upon binding to DNA breaks, activated PARP cleaves NAD+ into nicotinamide and ADP-ribose and polymerizes the latter onto nuclear acceptor proteins including histones, tran Read More
-
-
-
Advances in Extracorporeal Detoxification by MARS Dialysis in Patients with Liver Failure
Authors: C. Campli, L. Verme, M.C. Andrisani, A. Armuzzi, M. Candelli, R. Gaspari and A. GasbarriniAlthough liver transplantation has become standard procedure for patients with liver failure, a number of issues in the management of these patients remains to be addressed. Alternative approaches have been tested, such as hepatocytes containing liver-support systems and filtration devices. However, the replacement of detoxification has been difficult, as the majority of toxins accumulating in liver failure is albumin-b Read More
-
Volumes & issues
-
Volume 32 (2025)
-
Volume 31 (2024)
-
Volume 30 (2023)
-
Volume 29 (2022)
-
Volume 28 (2021)
-
Volume 27 (2020)
-
Volume 26 (2019)
-
Volume 25 (2018)
-
Volume 24 (2017)
-
Volume 23 (2016)
-
Volume 22 (2015)
-
Volume 21 (2014)
-
Volume 20 (2013)
-
Volume 19 (2012)
-
Volume 18 (2011)
-
Volume 17 (2010)
-
Volume 16 (2009)
-
Volume 15 (2008)
-
Volume 14 (2007)
-
Volume 13 (2006)
-
Volume 12 (2005)
-
Volume 11 (2004)
-
Volume 10 (2003)
-
Volume 9 (2002)
-
Volume 8 (2001)
-
Volume 7 (2000)
Most Read This Month
Article
content/journals/cmc
Journal
10
5
false
en
